Skip to main navigation Skip to search Skip to main content

Successful treatment of KCNJ11 neonatal diabetes without insulin

Translated title of the contribution: Successful treatment of KCNJ11 neonatal diabetes without insulin
1 Citation (Scopus)

Abstract

In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).

Translated title of the contributionSuccessful treatment of KCNJ11 neonatal diabetes without insulin
Original languageDanish
JournalUgeskrift for Laeger
Volume180
Issue number46
ISSN0041-5782
Publication statusPublished - 12 Nov 2018

Fingerprint

Dive into the research topics of 'Successful treatment of KCNJ11 neonatal diabetes without insulin'. Together they form a unique fingerprint.

Cite this